The United States FDA has approved a drug made by GW pharmaceuticals that is comprised of CBD (Cannabidiol). The drug is called “Epidiolex™” and was designed to treat seizures and conditions such as epilepsy. CBD is a non psychoactive component found in small amounts in most
cannabis strains (although with an increased demand the market is responding with more strains high in CBD). Physicians will investigate the affects of the medication on patients with approval from the FDA. The program is being carried out under the FDA’s informal so-called “compassionate” IND program that made federally-grown medical cannabis available to a fortunate few starting in the 70’s. Here is a great write-up with much more information: http://www.beyondthc.com/comes-now-epidiolex-fda-approves-ind-studies-of-cbd/
CANNABIS PATIENT RESOURCE
CPR is a blog hosted by CBD Professionals. CPR's aim is to help qualified medical cannabis patients keep abreast of the latest information on California's rapidly changing laws impacting patients' legal rights.